Fortrea Holdings (FTRE) Interest Coverage Ratio (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Interest Coverage Ratio came in at 1.59 in Q2 2026, up 105.78% YoY from 0.77 in Q2 2025, and up 1195.26% on a QoQ basis from 0.15 in Q1 2026.
Fortrea Holdings (FTRE) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of Interest Coverage Ratio data on file, last reported at 1.59 in Q2 2026.
- Quarterly Interest Coverage Ratio rose 105.78% year-over-year to 1.59 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.14 (up 99.54% YoY) and the FY2025 annual result came in at 2.39, down 61.53% from the prior year.
- Interest Coverage Ratio grew to 1.59 in Q2 2026, from 0.15 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 141.0 in Q1 2023 to a low of 27.52 in Q2 2025.
- A 5-year average of 6.49 and a median of 0.31 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio surged 209.66% — and 2025, when it plunged 2582.2%.
- Tracing FTRE's Interest Coverage Ratio over 5 years: stood at 0.28 in 2022, then plunged by 481.78% to 1.08 in 2023, then soared by 209.66% to 1.19 in 2024, then sank by 167.09% to 0.8 in 2025, then jumped by 300.09% to 1.59 in 2026.
- The last three Interest Coverage Ratio figures came in at 1.59 (Q2 2026), 0.15 (Q1 2026), and 0.8 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn | 1.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59 |
| Mar 31, 2026 | -0.15 |
| Dec 31, 2025 | -0.80 |
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -27.53 |
| Mar 31, 2025 | -15.21 |
| Dec 31, 2024 | 1.19 |
| Sep 30, 2024 | -0.57 |
| Jun 30, 2024 | -1.03 |
| Mar 31, 2024 | -0.75 |
| Dec 31, 2023 | -1.08 |
| Sep 30, 2023 | 0.17 |
| Jun 30, 2023 | 0.53 |
| Mar 31, 2023 | 141.00 |
| Dec 31, 2022 | 0.28 |